Rankings
▼
Calendar
FOLD Q4 2022 Earnings — Amicus Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
FOLD
Amicus Therapeutics, Inc.
$5B
Q4 2022 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$88M
+7.2% YoY
Gross Profit
$79M
89.3% margin
Operating Income
-$42M
-48.0% margin
Net Income
-$56M
-63.4% margin
EPS (Diluted)
$-0.20
QoQ Revenue Growth
+7.8%
Cash Flow
Operating Cash Flow
-$81M
Free Cash Flow
-$83M
Stock-Based Comp.
$19M
Balance Sheet
Total Assets
$724M
Total Liabilities
$601M
Stockholders' Equity
$123M
Cash & Equivalents
$149M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$88M
$82M
+7.2%
Gross Profit
$79M
$74M
+5.9%
Operating Income
-$42M
-$72M
+41.3%
Net Income
-$56M
-$83M
+32.9%
Geographic Segments
Non-US
$54M
61%
UNITED STATES
$34M
39%
← FY 2022
All Quarters
Q1 2023 →